Zevra Therapeutics Correlations

ZVRA Stock

9.50 0.07 0.74%

The current 90-days correlation between Zevra Therapeutics and Akebia Ther is 0.22 (i.e., Modest diversification). The correlation of Zevra Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Zevra Therapeutics Correlation With Market

Good diversification

The correlation between Zevra Therapeutics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zevra Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zevra Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Zevra Stock refer to our How to Trade Zevra Stock guide.

Moving together with Zevra Stock

0.63	VANI	Vivani Medical	Pair Corr
0.65	VAXX	Vaxxinity	Pair Corr
0.63	VCEL	Vericel Corp Ord	Pair Corr
0.72	VCYT	Veracyte	Pair Corr
0.7	SABSW	SAB Biotherapeutics	Pair Corr
0.75	VRNA	Verona Pharma PLC	Pair Corr
0.69	VSTM	Verastem Upward Rally	Pair Corr

Moving against Zevra Stock

0.69	DTIL	Precision BioSciences	Pair Corr
0.61	DOMH	Dominari Holdings	Pair Corr
0.59	VALN	Valneva SE ADR	Pair Corr
0.51	DRMA	Dermata Therapeutics	Pair Corr
0.47	VERU	Veru Inc Earnings Call This Week	Pair Corr
0.42	DNTH	Dianthus Therapeutics	Pair Corr
0.73	EDSA	Edesa Biotech Fiscal Year End 20th of December 2024	Pair Corr
0.71	VINC	Vincerx Pharma	Pair Corr
0.71	VIRX	Viracta Therapeutics	Pair Corr
0.69	VXRT	Vaxart Inc	Pair Corr
0.61	EDIT	Editas Medicine	Pair Corr
0.53	DWTX	Dogwood Therapeutics, Symbol Change	Pair Corr
0.52	VRCA	Verrica Pharmaceuticals Buyout Trend	Pair Corr
0.45	VTGN	VistaGen Therapeutics	Pair Corr
0.42	VRPX	Virpax Pharmaceuticals	Pair Corr
0.38	CDTTW	Conduit Pharmaceuticals	Pair Corr

Related Correlations Analysis

	RNAZ	FBIO	AKBA	TRVN	RVPH	GLUE	PMVP	PHVS	TYRA
RNAZ		-0.32	-0.28	0.29	0.03	-0.31	0.07	0.04	0.44	RNAZ
FBIO	-0.32		0.27	0.21	-0.19	0.28	0.3	0.47	-0.12	FBIO
AKBA	-0.28	0.27		0.36	-0.57	0.85	0.75	0.65	-0.76	AKBA
TRVN	0.29	0.21	0.36		-0.28	0.32	0.67	0.52	-0.04	TRVN
RVPH	0.03	-0.19	-0.57	-0.28		-0.57	-0.52	-0.46	0.57	RVPH
GLUE	-0.31	0.28	0.85	0.32	-0.57		0.69	0.66	-0.81	GLUE
PMVP	0.07	0.3	0.75	0.67	-0.52	0.69		0.64	-0.38	PMVP
PHVS	0.04	0.47	0.65	0.52	-0.46	0.66	0.64		-0.36	PHVS
TYRA	0.44	-0.12	-0.76	-0.04	0.57	-0.81	-0.38	-0.36		TYRA
	RNAZ	FBIO	AKBA	TRVN	RVPH	GLUE	PMVP	PHVS	TYRA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GLUE	+ 0.85	AKBA
PMVP	+ 0.75	AKBA
PMVP	+ 0.69	GLUE
PMVP	+ 0.67	TRVN
PHVS	+ 0.66	GLUE
PHVS	+ 0.65	AKBA

High negative correlations

TYRA	- 0.81	GLUE
TYRA	- 0.76	AKBA
GLUE	- 0.57	RVPH
RVPH	- 0.57	AKBA
PMVP	- 0.52	RVPH
PHVS	- 0.46	RVPH

Risk-Adjusted Indicators

There is a big difference between Zevra Stock performing well and Zevra Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zevra Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RNAZ	8.30	0.89	0.12	0.73	7.12	(12.13)	22.00	(11.54)	68.80
FBIO	3.16	(0.25)	0.00	(0.05)	0.00	0.00	7.65	(5.08)	26.13
AKBA	2.61	0.59	0.12	(0.77)	2.61	(3.40)	6.22	(4.11)	26.21
TRVN	11.02	(0.57)	0.00	(0.70)	0.00	0.00	27.82	(41.20)	99.50
RVPH	4.78	0.08	0.02	0.17	5.83	(5.53)	10.71	(9.86)	40.06
GLUE	5.04	1.29	0.22	(0.80)	3.76	(6.98)	7.42	(8.18)	102.66
PMVP	1.55	0.01	(0.03)	0.15	1.97	(1.97)	3.75	(3.64)	13.98
PHVS	2.93	0.50	0.08	(0.53)	3.14	(3.61)	7.76	(6.64)	21.41
TYRA	3.42	(0.44)	0.00	(2.27)	0.00	0.00	5.20	(6.06)	34.43

Zevra Therapeutics Corporate Management

Joshua MBA	Executive Officer	Profile
Sven Guenther	Chief Officer	Profile
Christopher Lauderback	Senior Manufacturing	Profile
Daniel Gallo	Senior Advocacy	Profile
Rene Braeckman	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC